Evidence map›Paper›PMID 25843606›Full record

ArticleMethods (San Diego, Calif.)2015

Long term perfusion system supporting adipogenesis.

Rosalyn D Abbott, Waseem K Raja, Rebecca Y Wang, Jordan A Stinson, Dean L Glettig, Kelly A Burke, David L Kaplan

Abstract read
In one paragraph

Article in Methods (San Diego, Calif.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Three-Dimensional Humanized Model of the Periodontal Gingival Pocket to Study Oral Microbiome.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  12. Fiber-Based Biopolymer Processing as a Route toward Sustainability.Advanced materials (Deerfield Beach, Fla.) · 2022
    Review
  13. Article
  14. Towards an Insulin Resistant Adipose Model on a Chip.Cellular and molecular bioengineering · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Rosalyn D AbbottDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States.
Waseem K RajaDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States; Department of Brain and Cognitive Science, MIT, Cambridge, MA, United States.
Rebecca Y WangDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States.
Jordan A StinsonDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States.
Dean L GlettigDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States; Biological Engineering, MIT, Cambridge, MA, United States.
Kelly A BurkeDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States; Department of Chemical and Biomolecular Engineering, University of Connecticut, Storrs, CT, United States.
David L KaplanDepartment of Biomedical Engineering, Science and Technology Center, Tufts University, 4 Colby St, Medford, MA 02155, United States. Electronic address: david.kaplan@tufts.edu.
Tufts University · USUniversity of Connecticut · US

Funding

Translational Bioreactors - Engineering Complex TissuesP41EB002520 · NIBIB · TUFTS UNIVERSITY MEDFORD · PI KAPLAN, DAVID L. · 2004 to 2018
$16.7M
Type Two Diabetes Mellitus Tissue Model to Investigate Insulin ResistanceF32DK093194 · NIDDK · TUFTS UNIVERSITY MEDFORD · PI BURKE, KELLY ANNE · 2012 to 2014
$124k
NIBIB NIH HHS P41 EB002520NIDDK NIH HHS F32-DK093194
6 · The paper itself

Abstract

Adipose tissue engineered models are needed to enhance our understanding of disease mechanisms and for soft tissue regenerative strategies. Perfusion systems generate more physiologically relevant and sustainable adipose tissue models, however adipocytes have unique properties that make culturing them in a perfusion environment challenging. In this paper we describe the methods involved in the development of two perfusion culture systems (2D and 3D) to test their applicability for long term in vitro adipogenic cultures. It was hypothesized that a silk protein biomaterial scaffold would provide a 3D framework, in combination with perfusion flow, to generate a more physiologically relevant sustainable adipose tissue engineered model than 2D cell culture. Consistent with other studies evaluating 2D and 3D culture systems for adipogenesis we found that both systems successfully model adipogenesis, however 3D culture systems were more robust, providing the mechanical structure required to contain the large, fragile adipocytes that were lost in 2D perfused culture systems. 3D perfusion also stimulated greater lipogenesis and lipolysis and resulted in decreased secretion of LDH compared to 2D perfusion. Regardless of culture configuration (2D or 3D) greater glycerol was secreted with the increased nutritional supply provided by perfusion of fresh media. These results are promising for adipose tissue engineering applications including long term cultures for studying disease mechanisms and regenerative approaches, where both acute (days to weeks) and chronic (weeks to months) cultivation are critical for useful insight.

Indexed as

AdipocytesAdipogenesisAdult Stem CellsAnimalsBiocompatible MaterialsCell Culture TechniquesHumansMaterials TestingPerfusionSilkTissue EngineeringTissue ScaffoldsBiocompatible MaterialsSilkAdipose tissue engineeringLong term culturePerfusionSilk scaffoldThree dimensional culture

Identifiers

PMID25843606
PMCPMC4526405
OpenAlexW1983255282

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.